Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 2
1995 1
1996 1
1997 2
1998 1
1999 1
2003 1
2004 1
2005 1
2007 1
2008 2
2009 2
2010 3
2012 4
2013 4
2014 2
2015 4
2016 2
2017 1
2018 7
2019 1
2020 2
2021 4
2022 3
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Variant Angina and Aborted Sudden Cardiac Death.
Kundu A, Vaze A, Sardar P, Nagy A, Aronow WS, Botkin NF. Kundu A, et al. Curr Cardiol Rep. 2018 Mar 8;20(4):26. doi: 10.1007/s11886-018-0963-1. Curr Cardiol Rep. 2018. PMID: 29520510 Review.
This review describes the epidemiology, pathogenesis, clinical spectrum, and management of variant angina, as well as outcomes in patients who present with aborted sudden cardiac death (ASCD). ...
This review describes the epidemiology, pathogenesis, clinical spectrum, and management of variant angina, as well as outcomes in pat …
Sotalol.
Hohnloser SH, Woosley RL. Hohnloser SH, et al. N Engl J Med. 1994 Jul 7;331(1):31-8. doi: 10.1056/NEJM199407073310108. N Engl J Med. 1994. PMID: 8202100 Review.
Sotalol is a novel antiarrhythmic agent combining beta-adrenergic-antagonist actions with the ability to increase cardiac repolarization and refractoriness. The drug's electrophysiologic and clinical profile is different from that of conventional beta-receptor antagonists. …
Sotalol is a novel antiarrhythmic agent combining beta-adrenergic-antagonist actions with the ability to increase cardiac repolarization and …
Pacing-facilitated proarrhythmia.
Tsikrikas S, Bramos D, Kollias G, Letsas KP, Efremidis M, Sideris A. Tsikrikas S, et al. Hellenic J Cardiol. 2012 Jul-Aug;53(4):327-8. Hellenic J Cardiol. 2012. PMID: 22796822 Free article.
The implantable cardioverter-defibrillator (ICD) has been proven to reduce the mortality of patients with life-threatening ventricular arrhythmias, and has become the therapy of choice for patients with aborted sudden cardiac death or poorly tolerated …
The implantable cardioverter-defibrillator (ICD) has been proven to reduce the mortality of patients with life-threatening ventricular arrhy …
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.
Masri A, Sherrid MV, Abraham TP, Choudhury L, Garcia-Pavia P, Kramer CM, Barriales-Villa R, Owens AT, Rader F, Nagueh SF, Olivotto I, Saberi S, Tower-Rader A, Wong TC, Coats CJ, Watkins H, Fifer MA, Solomon SD, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Meng L, Sohn RL, Wohltman A, Maron MS; REDWOOD-HCM Investigators. Masri A, et al. J Card Fail. 2024 Nov;30(11):1439-1448. doi: 10.1016/j.cardfail.2024.02.020. Epub 2024 Mar 15. J Card Fail. 2024. PMID: 38493832 Free article. Clinical Trial.

Three (8%) patients had asymptomatic reduction in LVEF < 50% (range: 41%-48%), all returning to normal after 2 weeks of washout. One patient with prior history of aborted sudden cardiac death experienced a fatal arrhythmia during the study. CONCLUSI

…

Three (8%) patients had asymptomatic reduction in LVEF < 50% (range: 41%-48%), all returning to normal after 2 weeks of washout. One pati

…
Sports-Related Sudden Cardiac Death Attributable to Myocarditis: A Systematic Review and Meta-analysis.
Quinn R, Moulson N, Wang J, Isserow S, McKinney J. Quinn R, et al. Can J Cardiol. 2022 Nov;38(11):1684-1692. doi: 10.1016/j.cjca.2022.07.006. Epub 2022 Jul 16. Can J Cardiol. 2022. PMID: 35850383 Review.
The objective was to ascertain the incidence of SrSCD or aborted sudden cardiac death (SCD) attributable to myocarditis in the general population. ...Risk assessment was performed with the Joanna Briggs Institute Critical Appraisal Checklist for Preval …
The objective was to ascertain the incidence of SrSCD or aborted sudden cardiac death (SCD) attributable to myoc …
Questionnaire in patients with aborted sudden cardiac death due to coronary spasm in Japan.
Sueda S, Shinohara T, Takahashi N, Shite J, Shoji T, Akao M, Kijima Y, Masuyama T, Miyaji T, Yamamoto K, Iwasaki Y, Yoshida R, Nakamura S, Ogino Y, Kimura K, Sasai M, Suzuki H, Wakatsuki T, Asajima H, Teragawa H, Ishikawa T, Kitamura K, Oda T, Nakayama T, Kobayashi Y, Sunada D, Yamaki M, Nishizaki F, Tomita Y, Usuda K, Fujinaga H, Kuramitsu S, Andou K, Kiyooka T, Kadota K, Ishii Y, Ohtani H, Maekawa Y, Taguchi E, Nakao K, Kobayashi N, Seino Y, Nakagawa H, Saito Y, Komuro I, Sasaki Y, Ikeda S, Yamaguchi O, Kakutani A, Imanaka T, Ishihara M, Ishii M, Kaikita K, Tsujita K. Sueda S, et al. Heart Vessels. 2020 Dec;35(12):1640-1649. doi: 10.1007/s00380-020-01644-7. Epub 2020 Jun 12. Heart Vessels. 2020. PMID: 32533313
OBJECTIVES: We investigated the medical or mechanical therapy, and the present knowledge of Japanese cardiologists about aborted sudden cardiac death (ASCD) due to coronary spasm. METHODS: A questionnaire was developed regarding the number of cases of …
OBJECTIVES: We investigated the medical or mechanical therapy, and the present knowledge of Japanese cardiologists about aborted s …
Advances in Ventricular Arrhythmia Ablation for Brugada Syndrome.
Chokesuwattanaskul R, Nademanee K. Chokesuwattanaskul R, et al. Card Electrophysiol Clin. 2022 Dec;14(4):685-692. doi: 10.1016/j.ccep.2022.08.006. Card Electrophysiol Clin. 2022. PMID: 36396185 Review.
Three decades have passed since the Brugada syndrome (BrS) clinical entity was introduced in the early 1990s. During the first 2 decades, treatment of patients with BrS was challenging because there were limited treatment options, and an implantable cardioverter-defibrilla …
Three decades have passed since the Brugada syndrome (BrS) clinical entity was introduced in the early 1990s. During the first 2 deca …
Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH, Gold MR. Klein MH, et al. Cardiol Clin. 2008 Aug;26(3):419-31, vi-vii. doi: 10.1016/j.ccl.2008.03.006. Cardiol Clin. 2008. PMID: 18538188 Review.
Sudden cardiac death is the leading cause of cardiac mortality, particularly among high-risk populations with known left ventricular systolic dysfunction. Multiple randomized clinical trials demonstrated a significant mortality benefit of the implantable cardioverte …
Sudden cardiac death is the leading cause of cardiac mortality, particularly among high-risk populations with known left ventricular systoli …
Autosomal Recessive Long QT Syndrome: Clinical Aspects and Therapy.
Righi D, Porco L, Di Mambro C, Gnazzo M, Baban A, Paglia S, Silvetti MS, Novelli A, Tozzi AE, Drago F. Righi D, et al. Pediatr Cardiol. 2023 Dec;44(8):1736-1740. doi: 10.1007/s00246-023-03266-y. Epub 2023 Aug 19. Pediatr Cardiol. 2023. PMID: 37597120
Three (30%) patients had compound heterozygosity and 7 (70%) had homozygous variants of the KCNQ1 gene, the latter showing deafness. Four patients (40%) presented aborted sudden cardiac death (aSCD): three with previous episodes of syncope (75%), the o …
Three (30%) patients had compound heterozygosity and 7 (70%) had homozygous variants of the KCNQ1 gene, the latter showing deafness. Four pa …
Transvenous versus subcutaneous implantable cardioverter defibrillators in young cardiac arrest survivors.
Morton MB, Mariani JA, Kistler PM, Patel H, Voskoboinik A. Morton MB, et al. Intern Med J. 2023 Nov;53(11):1956-1962. doi: 10.1111/imj.16259. Epub 2023 Nov 6. Intern Med J. 2023. PMID: 37929818 Review.
Secondary prevention implantable cardioverter defibrillators (ICDs) are indicated in young patients presenting with aborted sudden cardiac death (SCD) because of ventricular arrhythmias. Transvenous-ICDs (TV-ICDs) are effective, established therapies s …
Secondary prevention implantable cardioverter defibrillators (ICDs) are indicated in young patients presenting with aborted sudden …
54 results